Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1997-06-18
1999-07-20
MacMillan, Keith D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514370, 514340, 514366, 514365, A01N 4378, A61K 31425
Patent
active
059256575
ABSTRACT:
Disclosed herein are methods for reducing or preventing cytokine production associated with an inflammatory response, involving administering to a mammal a therapeutically-effective amount of a thiazolidinedione PPAR.gamma. agonist.
REFERENCES:
patent: 5594015 (1997-01-01), Kurtz et al.
Chemical Abstracts AN 1997:653205, Peraldi et al. Oct. 1997.
Chemical Abstracts AN 1994:692489, Ohsumi et al., Jan. 1994.
Chawla et al., "Peroxisome proliferator-activated receptor (PPAR) .gamma.:adipose-predominant expression and induction early in adipocyte differentiation," Endocrinol. 135:798-800, 1994.
Forman et al., "15-deoxy-.DELTA..sup.12, 14 -prostaglandin J.sub.2 is a ligand for the adipocyte determination factor PPAR.gamma.," Cell 83:803-812, 1995.
Hu et al., "Transdifferentiation of myoblasts by the adipogenic transcription factors PPAR.gamma. and C/EBP.alpha.," Proc. Natl. Acad. Sci. USA 92:9856-9860, 1995.
Kliewer et al., "A rostaglandin J.sub.2 metabolite binds peroxisome proliferator-activated receptor .gamma. and promotes adipocyte differentiation," Cell 83:813-819, 1995.
Lehmann et al., "An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor .gamma. (PPAR.gamma.)," J. Biol Chem. 270:12953-12956, 1995.
Lehmann et al., "Peroxisome proliferator-activated receptors .alpha. and .gamma. are activated by indomethacin and other non-steroidal andti-inflammatory drugs," J. Biol. Chem. 272:3406-3410, 1997.
Tontonoz et al., "mPPAR.gamma.2: tissue-specific regulator of an adipocyte enhancer," Genes Dev. 8:1224-1234, 1994.
Tontonoz et al., "Stimulation of adipogenesis in fibroblasts by PPAR.gamma.2, a lipid-avtivated transcription factor," Cell 79:1147-1156, 1994.
Peraldi et al., "Thiazolidinediones block tumor necrosis factor-.alpha.-induced inhibition of insulin signaling," J. Clin invest, 100:1863-1869, 1997.
Ohsumi et al., "Troglitazone prevents the inhibitory effects of inflammatory cytokines in insulin-induced adipocyte differentiation in 3T3-L1 cells," Endocrinology, 135:2279-2282, 1994.
Jiang Chengyu
Seed Brian
MacMillan Keith D.
The General Hospital Corporation
LandOfFree
Use of PPAR.gamma. agonists for inhibition of inflammatory cytok does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of PPAR.gamma. agonists for inhibition of inflammatory cytok, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of PPAR.gamma. agonists for inhibition of inflammatory cytok will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1322199